Recurrent Fetal Loss and Antiphospholipid Antibodies: Clinical and Therapeutic Aspects
Recurrent fetal losses indicate screening for antiphospholipid antibodies, especially after the third consecutive fetal loss, or when they occur after 12 weeks gestation or when the mother presents with thrombosis or other ailments of antiphospholipid syndrome. Fetal loss may be caused by thromboses...
Main Authors: | O. Blétry, A.-M. Piette |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1997-01-01
|
Series: | Infectious Diseases in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/S1064744997000288 |
Similar Items
-
RECURRENT FETAL LOSS IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (CASE REPORT)
by: Z S Alekberova, et al.
Published: (2000-02-01) -
THE ROLE OF CIRCULATING ANTIPHOSPHOLIPID ANTIBODIES IN THE FETAL LOSS SYNDROME DEVELOPMENT
by: M. S. Selkhadzhieva
Published: (2016-06-01) -
Antiphospholipid antibodies and recurrent miscarriage
by: Rai, Rajendra Singh
Published: (1999) -
Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscariages
by: Jeremić Katarina, et al.
Published: (2005-01-01) -
Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study
by: Yu Song, et al.
Published: (2017-01-01)